Isolated Subclinical Hyperthyrotropinemia in Obese Children: Does Levothyroxine (LT4) Improve Weight Reduction during Combined Behavioral Therapy?
Table 1
Characteristics of groups.
Group 1
Group 2
value
()
()
At baseline visit
Age (years)
10.0 ± 3.1
10.9 ± 3.0
0.324
Sex (M : F)
13 : 13
7 : 18
—
Weight (kg)
63.4 ± 23.0
62.4 ± 20.7
0.881
Height (cm)
147.1 ± 18.9
147.9 ± 14.9
0.870
BMI (kg/m2)
28.2 ± 4.2
27.8 ± 5.6
0.774
BMI -score (SD)
3.4 ± 1.11
2.9 ± 1.04
0.087
TSH (μIU/mL)
5.45 ± 0.86
4.45 ± 2.37
0.052
At follow-up visit
BMI (kg/m2)
27.9 ± 4.2
27.4 ± 4.6
0.719
BMI -score (SD)
3.17 ± 0.86
2.66 ± 0.92
0.072
TSH (μIU/mL)
3.59 ± 1.01
2.59 ± 2.63
0.039
Data are expressed as mean ± standard deviation. Group 1: combined (dietary/behavioral/physical activity) weight reduction program only. Group 2: combined (dietary/behavioral/physical activity) weight reduction program plus LT4 treatment.
